VAERS Explorer
Back to explore

Report #2854280

Received Aug 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
MD
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1——

Symptoms (1)

Product administered at inappropriate site

Symptom narrative

Alternatives Sites for Intramuscular Administration of Shingrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of vaccine administered at inappropriate site in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included lymph node excision (lymph nodes removed from patient's arm). Concurrent medical conditions included cancer. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccine administered at inappropriate site (Verbatim: Alternatives Sites for Intramuscular Administration of Shingrix). The outcome of the vaccine administered at inappropriate site was not applicable. Additional Information: GSK receipt date: 01-AUG-2025 Pharmacist had an adult female patient who is on cancer treatment and she has had her lymph nodes removed from her arm. Patient would like to received Shingrix first dose but she declined to have the injection on her deltoid muscle which led to vaccine administered at inappropriate site.

Current illness

Cancer

Medical history

Medical History/Concurrent Conditions: Lymph node excision (lymph nodes removed from patient's arm)